Eric P. Winer MD

PubMed

• Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer.
  Guilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, Kate E Dibble, Erica L Mayer
  Journal of the National Cancer Institute. 2026-10-01
• Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases.
  Thomas Grinda, Hillary M Heiling, Nabihah Tayob, Karen L Smith, Raechel Davis
  Breast. 2026-10-01
• 1 citations
  Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/...
  Nadine Tung, Fengmin Zhao, Angela DeMichele, Aleix Prat, Eric P Winer
  Journal of Clinical Oncology. 2026-08-20

Journal Articles

• Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer  
  Eric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
• Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer  
  Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, JAMA Oncology
• Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 Study  
  M C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology

Lectures

• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/11/2013
• 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS) 
  UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
• Breast Cancer, New Horizons, Current Controversies 
  Harvard Medical School, Boston, Massachusetts - 7/12/2012